Limited Diagnostic Utility of Postoperative C-Reactive Protein for Early Detection of Surgical Site Infections Following Posterior Scoliosis Correction Surgery

术后C反应蛋白在后路脊柱侧弯矫正术后早期检测手术部位感染中的诊断价值有限

阅读:1

Abstract

Background/Objectives: Surgical site infection (SSI) is a serious complication following scoliosis correction surgery. While CRP monitoring is commonly used after major orthopedic procedures such as joint arthroplasty, its utility for early SSI detection after scoliosis surgery remains unclear. The aim of this study was to evaluate the diagnostic value of postoperative serum C-reactive protein (CRP) concentrations for identifying early surgical site infections (SSI) in patients undergoing scoliosis correction surgery. Methods: A retrospective analysis was performed on a prospectively collected database of 358 patients who underwent posterior spinal fusion for scoliosis between 2014 and 2024 at a single orthopedic center. Patients were divided into idiopathic scoliosis (IS, n = 268) and non-idiopathic scoliosis (N-IS, n = 90) groups. Serum CRP concentrations were measured postoperatively on days 2 and 4 or 3 and 5. The incidence of early SSI and postoperative CRP trends were compared between patients with and without SSI. Results: The overall early SSI rate was 3.91% (IS: 2.24%, N-IS: 8.89%). A clear postoperative decline in CRP was observed in the non-SSI group. In contrast, only 2 patients with confirmed SSI demonstrated a rising CRP trend in the early postoperative period, indicating poor sensitivity of this marker for early infection detection. Conclusions: Postoperative CRP dynamics showed limited diagnostic value for early SSI detection. A rising CRP occurred in only a minority of infected cases. Therefore, CRP should not be used as a standalone marker, and clinical assessment remains essential for early SSI diagnosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。